Ampalayohan, Laarni Jane G.

HRN: 28-88-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
AMPICILLIN 1GM (VIAL)
04/19/2026
04/20/2026
IVT
2g
Q6 Anst
Pprom
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: